- Research works
- 26 ▲ 27% vs 2013–17
- Citations
- 618 23.4 per fractional work
- Top-10% rate
- 51.9% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Actelion (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Actelion (United States) specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.7× the share of its output that it takes of world research.
- MedicineField · 24.8 works4.7×
- Health SciencesDomain · 25.0 works4.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Actelion (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Endothelial Dysfunction, Echocardiography, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Cardiovascular Disease, Treatment and Guidelines.
- Global Burden
- Risk Factors
- Hospital Readmission
- Heart Failure
- Guidelines
- Cardiovascular Disease
- Right Heart Assessment
- Echocardiography
- Endothelial Dysfunction
- Pulmonary Hypertension
- Diagnosis
- Treatment
- Epidemiology
- B-Type Natriuretic Peptide
- Management
- Fibrosis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Endothelial Dysfunction14▲ 183×2 topics
- Echocardiography14▲ 190×2 topics
- Pulmonary Hypertension14▲ 309×1 topic
- Right Heart Assessment14▲ 1274×1 topic
- Diagnosis4▲ 13×4 topics
- Cardiovascular Disease3▲ 10×7 topics
- Treatment3▲ 8.3×3 topics
- Guidelines2▲ 20×4 topics
- Epidemiology2▲ 2.3×4 topics
- Heart Failure2▲ 20×4 topics
- B-Type Natriuretic Peptide2▲ 168×1 topic
- Hospital Readmission2▲ 168×1 topic
- Management2▲ 10.0×3 topics
- Risk Factors2▲ 5.8×4 topics
- Fibrosis1▲ 24×2 topics
- Global Burden1▲ 8.8×2 topics
Which research topics does Actelion (United States) publish most on?
By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management, Blood Pressure and Hypertension Studies and Cardiac Valve Diseases and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
- 2 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
- 3 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
- 4 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
- 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Actelion (United States)'s research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.